Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurovascular and hemodynamic responses to mental stress and exercise in severe COVID-19 survivors.
Faria D, Moll-Bernardes R, Testa L, Moniz CMV, Rodrigues EC, Mota JM, Souza FR, Alves MJNN, Ono BE, Izaias JE, Sales AO, Rodrigues TS, Salemi VMC, Jordão CP, De Angelis K, Craighead DH, Rossman MJ, Bortolotto LA, Consolim-Colombo FM, Irigoyen MCC, Seals DR, Negrão CE, Sales ARK. Faria D, et al. Among authors: mota jm. Am J Physiol Regul Integr Comp Physiol. 2023 Sep 1;325(3):R269-R279. doi: 10.1152/ajpregu.00111.2023. Epub 2023 Jul 14. Am J Physiol Regul Integr Comp Physiol. 2023. PMID: 37449870 Free PMC article.
High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil.
Polho GB, Cunha MT, Coelho MHM, Almeida-Silva J, Hidalgo Filho CM, Xavier EM, Crusoe NS, Atanazio MJ, de Vasconcellos VF, Horita VN, Freitas GF, Muniz DQ, Rocha V, Mota JM. Polho GB, et al. Among authors: mota jm. Clin Genitourin Cancer. 2024 Mar 24:102083. doi: 10.1016/j.clgc.2024.102083. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38658209
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.
Weinhäuser I, Pereira-Martins DA, Almeida LY, Hilberink JR, Silveira DRA, Quek L, Ortiz C, Araujo CL, Bianco TM, Lucena-Araujo A, Mota JM, Hogeling SM, Sternadt D, Visser N, Diepstra A, Ammatuna E, Huls G, Rego EM, Schuringa JJ. Weinhäuser I, et al. Among authors: mota jm. Sci Adv. 2023 Apr 14;9(15):eadf8522. doi: 10.1126/sciadv.adf8522. Epub 2023 Apr 14. Sci Adv. 2023. PMID: 37058562 Free article.
PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling.
Wanderley CWS, Maganin AGM, Adjafre B, Mendes AS, Silva CEA, Quadros AU, Luiz JPM, Silva CMS, Silva NR, Oliveira FFB, Gomes FIF, Restrepo JLJ, Speck-Hernandez CA, Turaça F, Silva GVL, Pigatto GR, Nakaya HI, Mota JM, Barroso-Sousa R, Alves-Filho JC, Cunha TM, Cunha FQ. Wanderley CWS, et al. Among authors: mota jm. Cancer Immunol Res. 2022 Nov 2;10(11):1299-1308. doi: 10.1158/2326-6066.CIR-22-0003. Cancer Immunol Res. 2022. PMID: 36083496
55 results